RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α
about
Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelAExamining the pathogenesis of breast cancer using a novel agent-based model of mammary ductal epithelium dynamicsAn early biomarker and potential therapeutic target of RUNX 3 hypermethylation in breast cancer, a system review and meta-analysisAssociations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women.Identification of differentially methylated genes in the malignant transformation of ovarian endometriosis.Genome-wide screening of genes regulated by DNA methylation in colon cancer development.Clinicopathological significance and potential drug target of RUNX3 in breast cancer.Wild type p53 transcriptionally represses the SALL2 transcription factor under genotoxic stressRUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells.Opposing effects of Runx2 and estradiol on breast cancer cell proliferation: in vitro identification of reciprocally regulated gene signature related to clinical letrozole responsivenessTumor suppressor function of RUNX3 in breast cancerProlyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer.RUNX1 prevents oestrogen-mediated AXIN1 suppression and β-catenin activation in ER-positive breast cancer.TrkB Promotes Breast Cancer Metastasis via Suppression of Runx3 and Keap1 ExpressionThe clinicopathological significance of RUNX3 hypermethylation and mRNA expression in human breast cancer, a meta-analysis.Dysregulation of Notch and ERα signaling in AhR-/- male mice.Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profilingThe RUNX family in breast cancer: relationships with estrogen signaling.RUNX family: Regulation and diversification of roles through interacting proteins.The RUNX family: developmental regulators in cancer.Hormone-sensing mammary epithelial progenitors: emerging identity and hormonal regulation.Relationship between RUNX1 and AXIN1 in ER-negative versus ER-positive Breast Cancer.The enigmatic role of RUNX1 in female-related cancers - current knowledge & future perspectives.Runx3 in Immunity, Inflammation and Cancer.RUNX3 is a prognostic marker and potential therapeutic target in human breast cancer.RUNX3 interacts with MYCN and facilitates protein degradation in neuroblastoma.MicroRNA-148a can regulate runt-related transcription factor 3 gene expression via modulation of DNA methyltransferase 1 in gastric cancerRunx Genes in Breast Cancer and the Mammary Lineage.Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer.miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3.Transcriptional regulation by RUNX3Epigenome-wide association studies without the need for cell-type composition.Combination immunohistochemistry for SMAD4 and Runt-related transcription factor 3 may identify a favorable prognostic subgroup of pancreatic ductal adenocarcinomas.EZH2 promotes cell proliferation by regulating the expression of RUNX3 in laryngeal carcinoma.Roles of RUNX in Solid Tumors.A Regulatory Role for RUNX1, RUNX3 in the Maintenance of Genomic Integrity.Runx3 and Cell Fate Decisions in Pancreas Cancer.Shugan Liangxue Decoction () down-regulates estrogen receptor α expression in breast cancer cells.Susceptibility loci affecting ERBB2/neu-induced mammary tumorigenesis in mice.
P2860
Q24293271-A049A0A8-3BE4-433C-AA50-4073835DB329Q28383242-06A755CA-4CC7-4FB9-A64C-8F1EB6B8AA4CQ33591859-4A4EE45C-9F90-4E2E-A08F-A7C17FDEED82Q33869600-3DD94D9C-BCA6-4AC8-8618-B9633276214BQ33927116-89CCD672-2A03-45A1-8863-BDF46BDB7438Q34437619-B66EE188-5F3E-4722-90C5-322B010BEED0Q34700919-8E3C42F7-3B14-46BC-ACCA-BA16EF12222EQ34989369-F22B225E-D902-4679-938F-2C57F1652704Q35240492-C050C027-295B-4421-9529-85F2AFA95638Q35751787-7265E6A4-4050-46DE-8A9E-9D370F4EBDDBQ35914643-00E76DFE-CB03-4530-B8C4-0FAAF8B39102Q36223271-FCFAED8C-8CF0-4992-99EE-2FF427DD9A13Q36637143-8B3D70BF-1256-4764-B588-1DF63440A64FQ36693852-66D0647E-58A1-4B41-9D6F-D307DBC286EDQ37226515-44607E9A-99FB-49A5-857C-8D34F4A5003DQ37369446-8586D116-83F3-43C9-A765-166F55029117Q37458486-E51B1FEF-199A-448C-8575-0BB086CC2A76Q38050410-21D0BF94-E31B-4D1D-AF03-C3D6668FF510Q38062515-51C5C841-9243-4B81-B097-05EFEF182604Q38319972-630EE4F1-EE8D-45E7-B97C-BEA8254AAD6BQ38590446-FD947632-9182-4F2A-AEFD-9445268AD877Q38722836-0A2F888B-F25A-44A5-A2EB-E3D947990F47Q38743681-F8441A2E-0B25-4E89-8A17-DD96C25DE6E0Q38904246-DD81E44C-7FBA-423E-8BDE-B0383E9C18DAQ39100545-64C15D2A-2B68-4CC7-A54C-A744AA3DD665Q39126205-310BCF6F-F14B-4A19-A266-DD63F1806847Q39172335-17CF21A9-2438-4608-B850-1738B6FAF6D6Q39181420-6949D0A2-9EC0-47CA-A998-E18F6CA90145Q39625095-3F2FA40F-EC93-4537-AA9A-1A50553060D1Q40545042-28C72C25-3D9E-4202-AD0A-FD3B09CAFC69Q41621654-75371E2D-1AC2-42E0-94D2-29CBEE2A4044Q45316828-AE4721DE-A1B3-4A2A-AFE7-8FF21EEB13EEQ46690173-C1A09A68-33E1-4EE8-9AE8-5A636A307D79Q47144602-E0077247-1F41-47EA-BC80-8989F41C0223Q47970270-EA2FF244-D96F-41B3-9FC7-65424322EFABQ50796410-52240E96-D8EC-4DAD-81FA-1C5B749BA886Q51097592-C29DB4B8-4915-4EB0-ACDF-37CAEE6F1129Q51097608-4BAAF45B-946F-4BF4-AA5C-6F8CF643E2EDQ53208186-587270AB-45D8-452B-95CE-0BE8AB586AE1Q53776269-8A5C0109-F181-4E87-9D46-48415E92E9CE
P2860
RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α
@en
type
label
RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α
@en
prefLabel
RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α
@en
P2093
P2860
P356
P1433
P1476
RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α
@en
P2093
M Salto-Tellez
Y-H N Tsang
P2860
P2888
P304
P356
10.1038/ONC.2011.252
P407
P577
2011-06-27T00:00:00Z
P6179
1035927047